Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 221 (ZNF221)
- Target
- ZNF221
- Molecular classification
- Transcription factor, C2H2-type zinc finger protein, Krüppel-associated box (KRAB) domain protein
01
Overview
Zinc finger protein 221 (ZNF221) is a protein-coding gene encoding a member of the Krüppel C2H2-type zinc-finger protein family, specifically classified as a Krüppel-associated box (KRAB) domain-containing transcription factor[2][6]. ZNF221 is predicted to function as a sequence-specific DNA-binding transcription factor involved in the regulation of gene expression by RNA polymerase II, mainly acting as a transcriptional regulator or repressor[2][6]. Zinc finger proteins, including ZNF221, are characterized by their ability to bind DNA through conserved C2H2 zinc finger motifs, typically affecting gene transcription and related cellular processes such as differentiation, apoptosis, and proliferation[1][3][6]. While zinc finger proteins as a broader class have diverse roles in various biological and disease contexts, there is currently no direct evidence that ZNF221 is a validated or druggable therapeutic target, nor are any drugs or biomarkers specifically linked to this protein.
- Other names
- ZNF221zinc finger protein 221
02
Biological functions
Regulation of DNA-templated transcriptionDNA binding (sequence-specific)gene expressiontranscriptional repressionpossible roles in cell differentiationcell proliferationapoptosismaintenance of the nucleolus
03
Disease associations
Other (no direct link to major therapeutic disease roles such as cancer, inflammation, infection, etc., established for ZNF221 specifically)
Beyond the preview
Go deeper on Zinc finger protein 221 (ZNF221).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zinc finger protein 221 (ZNF221).